blog

What and When to Submit to the IRB?

By Elizabeth Gargill on Wed, Apr 29, 2020 | 1 min read

Insights from Advarra on Managing Changes to Patient Enrollment & Engagement due to COVID-19

Get an IRB's perspective on managing clinical trial enrollment modifications due to COVID-19 by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra.

Topics: Patient Engagement, Pharma15 Live!, COVID-19, Clinical Trial Enrollment, Institutional Review Board, Rob Laurens, IRB

 
Subscribe To Our Blog